Health Technology Assessment (HTA) is a systematic, evidence-based process used in public health to evaluate the clinical effectiveness, safety, cost-effectiveness, social impact, and ethical implications of health technologies. These technologies include medicines, vaccines, medical devices, diagnostic tools, digital health solutions, and healthcare interventions. HTA supports policymakers and health system leaders in making informed decisions about which technologies should be adopted, reimbursed, or scaled within healthcare systems. By comparing benefits, risks, and costs, HTA helps ensure the efficient use of limited health resources while maximizing population health outcomes. In public health, health technology assessment plays a crucial role in improving access to effective innovations, strengthening health system sustainability, and promoting equity. It also supports transparency and accountability in decision-making. Overall, HTA contributes to evidence-driven policies that enhance quality of care, affordability, and long-term health system performance.
Title : Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries
Sebastiano Venturi, Department of Public Health of Rimini, Italy
Title : Specific strategies over the life course for early identification, prevention, treatment, and long-term support
Christopher Ashton, Center for Recovery, Canada
Title : Population health, public health and the social determinants of health: The state of the science
Adele Ann Webb, Strategic Education, Inc., United States
Title : The nutritional management of healthy menu plans
Iuliana Vintila, Dunărea de Jos University of Galați, Romania
Title : Healthcare system profiles and pandemic outcomes: A cross-country multi-dimensional scaling analysis of Cuba, Spain, Italy, and Germany
Giuseppe Orlando, University of Bari Aldo Moro, Italy
Title : Change your genes – change your life: Epigenetics of longevity
Kenneth R Pelletier, USCF School of Medicine, United States